What laboratory and imaging tests should be ordered to evaluate a patient with elevated liver enzymes?

Evaluation of Elevated Liver Enzymes

Order a core panel of laboratory tests including hepatitis B surface antigen, hepatitis C antibody, ferritin with transferrin saturation, immunoglobulin G with autoantibodies (ANA, ASMA, anti-LKM), and anti-mitochondrial antibody, along with abdominal ultrasound as first-line imaging. 1

Laboratory Testing Strategy

Core Panel (First-Line Tests)

The initial workup should be guided by the pattern of enzyme elevation to determine whether the injury is hepatocellular (elevated ALT/AST) or cholestatic (elevated ALP/GGT) 1, 2.

Essential laboratory tests include:

• Hepatitis B surface antigen (HBsAg) and hepatitis C antibody - to identify viral hepatitis 1
• Ferritin and transferrin saturation - transferrin saturation >45% suggests hemochromatosis 1
• Immunoglobulin G with autoantibodies (ANA, ASMA, anti-LKM) - elevated IgG with positive autoantibodies indicates autoimmune hepatitis 1
• Anti-mitochondrial antibody (AMA) - positive in primary biliary cholangitis when cholestatic pattern present 1
• Complete blood count with platelets - helps assess for advanced disease 3
• Serum albumin - marker of hepatic synthetic function 4

Pattern-Specific Considerations

For hepatocellular pattern (ALT/AST predominant):

• Calculate the AST:ALT ratio - ratio >2 suggests alcohol-induced liver disease, while <1 suggests metabolic/NAFLD 2
• If ALT >1000 U/L, add hepatitis A, hepatitis E, and cytomegalovirus testing 1

For cholestatic pattern (ALP/GGT predominant):

• Confirm hepatic origin by checking GGT if ALP elevated in isolation 2
• Consider PSC if patient has inflammatory bowel disease or autoimmune history 1

Extended Panel (Second-Line Tests)

Reserve these for patients with no clear cause after core panel 1:

• Alpha-1 antitrypsin level - for alpha-1 antitrypsin deficiency 2, 3
• Ceruloplasmin - for Wilson disease (especially if age <40) 2, 3
• Celiac antibodies (tissue transglutaminase) - celiac disease can cause elevated transaminases 3
• Thyroid function tests - thyroid disorders can elevate AST 2

Imaging Strategy

First-Line Imaging: Abdominal Ultrasound

Ultrasound abdomen is the appropriate initial imaging study for evaluating elevated liver enzymes 2. It provides:

• Detection of hepatic steatosis - sensitivity 84.8% and specificity 93.6% for moderate-to-severe fatty infiltration (>30% fat content) 2
• Assessment for biliary dilatation - identifies extrahepatic cholestasis requiring urgent intervention 1
• Evaluation of liver morphology - detects cirrhosis, masses, or infiltrative disease 4
• Portal hypertension signs - splenomegaly, ascites, varices 4

Important caveat: Ultrasound sensitivity drops to 53-65% for mild steatosis (<30% fat), and specificity deteriorates with concurrent inflammation or fibrosis 2.

Advanced Imaging

Consider MRI/MRCP when:

• PSC is suspected (cholestatic pattern with inflammatory bowel disease) - no serological markers exist for PSC 1
• Ultrasound shows dilated bile ducts requiring further characterization 1
• Hepatic mass or vascular abnormality needs clarification 4

Elastography (ultrasound or MRI-based) provides non-invasive assessment of hepatic fibrosis and steatosis 4.

Clinical Context Requirements

Before ordering tests, obtain specific historical details 1:

Critical history elements:

• Alcohol intake - quantify in units per week, consider AUDIT-C screening 1
• Medications - prescribed, over-the-counter, herbal supplements, illicit drugs 1
• Metabolic syndrome features - central obesity, hypertension, diabetes, dyslipidemia (NAFLD risk) 1, 3
• Viral hepatitis risk factors - ethnicity, country of birth, injection drug use, transfusions 1
• Autoimmune/inflammatory bowel disease - personal or family history 1
• Muscle injury or strenuous exercise - can elevate AST without liver disease 2

Physical examination findings:

• BMI and waist circumference 1
• Hepatosplenomegaly, ascites, jaundice, spider angiomata 1

Common Pitfalls to Avoid

1. Don't simply repeat the same tests - 84% of abnormal liver tests remain abnormal at 1 month, and 75% at 2 years. Proceed with etiologic workup unless high suspicion for transient cause 1

2. Isolated ferritin elevation - commonly seen in dysmetabolic iron overload (NAFLD, alcohol) and does NOT indicate hemochromatosis without elevated transferrin saturation 1

3. AST elevation without ALT - consider non-hepatic causes including hemolysis, myopathy, thyroid disease, or exercise 2

4. Dilated bile ducts on ultrasound - requires urgent assessment and possible hospital referral depending on clinical context 1

Urgent Referral Indicators

Immediate specialist or emergency referral required for 1:

• Unexplained clinical jaundice
• Suspicion of hepatic or biliary malignancy
• Prolonged INR with elevated bilirubin (acute liver failure)
• Dilated bile ducts suggesting obstruction

Algorithmic Approach Summary

1. Confirm abnormality - repeat if clinically indicated for transient causes
2. Determine pattern - hepatocellular vs. cholestatic vs. mixed
3. Order core laboratory panel - hepatitis B/C, ferritin/transferrin saturation, immunoglobulins/autoantibodies, AMA, CBC, albumin
4. Obtain abdominal ultrasound - assess for steatosis, biliary dilatation, structural abnormalities
5. Add extended panel if core workup unrevealing - alpha-1 antitrypsin, ceruloplasmin, celiac antibodies, thyroid function
6. Consider advanced imaging (MRI/MRCP) for specific indications - PSC, biliary obstruction, masses
7. Refer to specialist if specific treatable disease identified (viral hepatitis, autoimmune hepatitis, PBC, PSC, hemochromatosis) or if diagnosis remains unclear 1

This systematic approach identifies the most common causes (NAFLD, alcohol-related liver disease) while efficiently screening for treatable conditions that impact long-term morbidity and mortality 1, 3.